Phospho-EIF2S1 (Ser49) Antibody

What is the functional significance of EIF2S1 phosphorylation at Ser49?

Phosphorylation of EIF2S1 (eIF2α) at Ser49 (sometimes referred to as Ser51 when counting the initiator methionine) plays a critical role in protein synthesis regulation. When phosphorylated, EIF2S1 functions as a global protein synthesis inhibitor by stabilizing the eIF2-GDP-eIF2B complex, preventing the GDP/GTP exchange reaction necessary for translation initiation . This phosphorylation is central to the integrated stress response (ISR), where it attenuates cap-dependent translation while simultaneously promoting the preferential translation of ISR-specific mRNAs, particularly stress-response transcriptional activators like ATF4 and QRICH1 . This mechanism allows cells to conserve resources during stress conditions while initiating adaptive gene expression programs to restore cellular homeostasis .

How does EIF2S1 phosphorylation connect to autophagy and cellular stress response pathways?

EIF2S1 phosphorylation creates a critical link between the unfolded protein response (UPR) and autophagy pathways. Research using EIF2S1 phosphorylation-deficient (S51A) cells has demonstrated that this modification is essential for the nuclear translocation of transcription factors TFEB and TFE3 during endoplasmic reticulum (ER) stress . These transcription factors regulate autophagic gene expression. Additionally, EIF2S1 phosphorylation mediates the transcriptional activation of ATF4 and DDIT3/CHOP, which increase transcription of autophagy genes required for autophagosome formation, elongation, and function . Beyond UPR, EIF2S1 also responds to mitochondrial damage, where phosphorylation by EIF2AK1/HRI promotes its relocalization to the mitochondrial surface, triggering PRKN-independent mitophagy .

Which kinases phosphorylate EIF2S1 and under what conditions?

EIF2S1 serves as a substrate for at least four distinct stress-responsive kinases:

Each kinase responds to specific cellular stressors, creating a convergent stress response pathway through EIF2S1 phosphorylation . This phosphorylation then triggers downstream signaling cascades appropriate to the specific stress condition, allowing for a coordinated cellular response.

What are the optimal experimental conditions for detecting phosphorylated EIF2S1?

For optimal detection of phosphorylated EIF2S1, several key methodological considerations should be addressed:

Western Blot Protocol:

• Sample preparation: Lysates should be prepared with phosphatase inhibitors to prevent dephosphorylation

• Dilution range: 1:500-1:50000 (antibody-dependent)

• Positive controls: Calyculin A-treated cells provide reliable positive controls for phospho-EIF2S1 detection

• Starvation induction: Cell starvation effectively triggers EIF2S1 phosphorylation as seen in the HeLa cell model

Immunofluorescence:

• Fixation method: Methanol fixation has been demonstrated to provide optimal antigen preservation

• Dilution range: 1:100-1:1600

• Cell types: HeLa cells show robust phospho-EIF2S1 signals after appropriate stress induction

Flow Cytometry:

• Recommended concentration: 0.5 μg per 10^6 cells in 100 μl suspension

• Permeabilization: Required for intracellular staining of phospho-EIF2S1

Researchers should validate each protocol in their specific experimental system, as detection sensitivity may vary between different cell types and stress conditions .

How can I distinguish between phosphorylation at Ser49 versus Ser51 sites in EIF2S1?

The discrepancy between Ser49 and Ser51 naming conventions primarily arises from different methods of residue numbering, with some sources counting the initiator methionine (resulting in Ser51) and others not (resulting in Ser49) . To experimentally distinguish phosphorylation at these sites:

• Site-specific antibodies: Use antibodies specifically raised against either phospho-Ser49 or phospho-Ser51 epitopes. Confirm specificity using phosphopeptide competition assays .

• Mutational analysis: Generate site-directed mutations (S49A and S51A) and assess phosphorylation status with general phospho-serine antibodies .

• Mass spectrometry: LC-MS/MS analysis can precisely identify which serine residue is phosphorylated based on the mass shift and fragmentation pattern.

• Phosphopeptide mapping: In vitro kinase assays with purified kinases can help determine site specificity, as demonstrated in studies using GST-eIF2α-AAA-S51-AAA and GST-eIF2α-AAA-A51-AAA mutants .

Research by Dey et al. found that in the PKR-eIF2α complex, "the Ser51 position has not been accurately assigned because 11 residues connecting Ser49 to Lys60 are substantially disordered," highlighting the structural complexity that contributes to this confusion .

What are the key considerations when interpreting Western blot results for phospho-EIF2S1?

When interpreting Western blot results for phospho-EIF2S1:

• Specificity validation: Confirm antibody specificity using:

  • Phosphopeptide competition assays

  • Phosphatase treatment controls

  • Phosphorylation-deficient mutants (S49A/S51A) as negative controls

• Signal normalization: Always normalize phospho-EIF2S1 signal to total EIF2S1 levels to accurately assess the phosphorylation state rather than protein expression changes.

• Molecular weight verification: Confirm detection at the expected molecular weight (36-40 kDa) .

• Stress-specific patterns: Different stressors produce distinct phosphorylation kinetics:

  • ER stress (tunicamycin/thapsigargin): Sustained phosphorylation via PERK

  • Viral infection: Rapid phosphorylation via PKR

  • Nutrient deprivation: Gradual phosphorylation via GCN2

• Temporal dynamics: EIF2S1 phosphorylation is often transient due to negative feedback through GADD34 induction. Time-course analyses are essential for accurate interpretation .

• Effects of mutations: Phosphomimetic mutations (S49D/S51D) can dramatically alter protein stability and ubiquitination patterns compared to wild-type or non-phosphorylatable mutants (S49A/S51A) .

How does phosphorylation of EIF2S1 affect its stability and degradation pathways?

Research on EIF2S1 stability has revealed fascinating phosphorylation-dependent regulation mechanisms:

• Differential stability: Phosphorylation of EIF2S1 at Ser51 significantly enhances its stability. Cycloheximide (CHX) chase experiments demonstrated that while non-phosphorylated EIF2S1 and S51A mutants showed half-lives of approximately 16 and 6 hours respectively, the phosphomimetic S51D mutant remained stable with minimal degradation even after 16 hours of CHX treatment .

• Ubiquitination protection: Phosphorylation at Ser51 markedly inhibits EIF2S1 ubiquitination. In vitro ubiquitination assays detected clear poly-ubiquitin bands on wild-type EIF2S1 and S51A mutants, while S51D mutants showed significantly reduced ubiquitination .

• CHIP-mediated degradation: The CHIP (C-terminus of HSC70-interacting protein) E3 ligase specifically targets non-phosphorylated EIF2S1 for degradation, promoting polyubiquitination of wild-type and S51A mutant EIF2S1, but not the S51D phosphomimetic variant .

• Stress-response implications: This phosphorylation-dependent stability regulation creates a self-reinforcing mechanism whereby stress-induced phosphorylation not only activates EIF2S1's translational control functions but also protects it from degradation, allowing for sustained integrated stress response signaling .

This phosphorylation-dependent protection from degradation represents an additional layer of EIF2S1 regulation beyond its well-established role in translation inhibition.

What is the role of EIF2S1 phosphorylation in neuronal functions and neurodegenerative diseases?

EIF2S1 phosphorylation plays critical roles in neuronal development, plasticity, and neurodegeneration:

• Neuronal plasticity: Phosphorylation of eIF2α at Ser51 is a conserved regulatory mechanism involved in synaptic plasticity and long-term memory formation . The controlled phosphorylation-dephosphorylation cycle appears essential for normal cognitive function.

• Development and diapause: In C. elegans, phosphorylation of EIF2S1 at Ser49 in specific chemosensory neurons (ASI neuron pair) by PEK-1/PERK promotes entry into dauer diapause, a developmental alternative triggered by adverse environmental conditions . This suggests conserved neuronal roles in sensing and responding to environmental stress.

• Nutrient sensing pathways: Constitutive expression of phosphomimetic EIF2S1 (S49D) in ASI sensory neurons confers dramatic effects on growth, metabolism, and reproduction in adult animals, phenocopying systemic responses to starvation . This demonstrates how neuronal EIF2S1 phosphorylation can coordinate organism-wide metabolic responses.

• Neurodegenerative implications: Dysregulated EIF2S1 phosphorylation is implicated in several neurodegenerative disorders:

  • Excessive phosphorylation contributes to protein synthesis inhibition in neurodegenerative disease models

  • Persistent activation of the integrated stress response through EIF2S1 phosphorylation may drive neuronal dysfunction in Alzheimer's and Parkinson's diseases

The cell-type specific consequences of EIF2S1 phosphorylation emphasize the importance of tissue-specific investigation in both normal neuronal function and disease states.

How does EIF2S1 phosphorylation influence the assembly of the eIF2 complex?

EIF2S1 phosphorylation has significant effects on eIF2 complex assembly and function:

• Ternary complex formation: Phosphorylated EIF2S1 forms a ternary complex with GTP and initiator tRNA (tRNAᵢᴹᵉᵗ) that binds to the 40S ribosomal subunit . This complex is essential for subsequent mRNA binding and formation of the 43S pre-initiation complex (43S PIC) .

• Subunit independence: Research using co-immunoprecipitation experiments with EIF2 subunit variants demonstrated that binding of EIF2α (EIF2S1) and EIF2β (EIF2S2) to EIF2γ (EIF2S3) is largely independent of each other. Variants with mutations D403R and V281R, while unable to interact with either EIF2S1 or EIF2S3, maintained largely intact binding with the respective other subunit . This indicates that either subunit can form a dimeric complex with EIF2γ independently.

• eIF2B interaction: Phosphorylation of EIF2S1 at Ser51 dramatically alters its interaction with eIF2B, the guanine nucleotide exchange factor required for recycling eIF2-GDP to eIF2-GTP. Mutational studies in yeast support a conserved role for eIF2Bα in providing a binding site for phosphorylated EIF2S1, where this binding inhibits the exchange factor activity of eIF2B .

• Complex recycling: For eIF2 to recycle and catalyze another round of initiation, the GDP bound to eIF2 must exchange with GTP through a reaction catalyzed by eIF2B . Phosphorylation of EIF2S1 stabilizes the eIF2-GDP-eIF2B complex, preventing this exchange and inhibiting translation initiation .

These findings highlight the multifaceted role of EIF2S1 phosphorylation in modulating eIF2 complex dynamics and translational control.

What strategies can be employed to overcome non-specific binding of phospho-EIF2S1 antibodies?

Non-specific binding of phospho-EIF2S1 antibodies can significantly impact experimental outcomes. Implement these strategies to improve specificity:

• Antibody validation protocols:

  • Use phosphopeptide blocking: Pre-incubate antibodies with the phosphopeptide immunogen (corresponding to human EIF2S1 phospho-S49)

  • Include phosphorylation-deficient mutants (S49A) as negative controls

  • Compare multiple antibody clones with different epitopes targeting the same phosphorylation site

• Optimized immunoblotting conditions:

  • Titrate antibody concentration carefully: Begin with 1:1000 dilution and adjust to minimize background

  • Extended blocking: Use 5% BSA in TBST for 2 hours at room temperature

  • Add 0.1% SDS to antibody dilution buffer to reduce non-specific interactions

  • Implement more stringent washing: Increase wash steps to 4-5 times with 0.1% Tween-20

• Sample preparation refinements:

  • Maintain phosphorylation status with phosphatase inhibitor cocktails

  • Optimize lysis buffers with reduced detergent to preserve epitope structure

  • Perform immunoprecipitation to concentrate the target protein before detection

• Signal validation:

  • Always confirm phospho-signals with expected molecular weight (36-40 kDa)

  • Use appropriate positive controls such as Calyculin A-treated cells, which show enhanced phosphorylation

  • Validate with alternative techniques like mass spectrometry to confirm phosphorylation sites

These approaches significantly improve the signal-to-noise ratio and allow for confident interpretation of phospho-EIF2S1 data.

How can researchers differentiate between the biological effects of Ser49 versus Ser51 phosphorylation?

Differentiating between the biological effects of Ser49 and Ser51 phosphorylation requires careful experimental design:

• Site-specific mutational analysis:

  • Generate cell lines with single point mutations (S49A, S51A, S49D, S51D)

  • Create double mutants (S49A/S51A, S49D/S51D) to assess potential synergistic effects

  • Use CRISPR/Cas9 genome editing for physiological expression levels

• Kinase-specific activation:

  • Selectively activate specific EIF2S1 kinases that may preferentially target one site:

    • PERK activation with tunicamycin

    • PKR activation with poly(I:C)

    • GCN2 activation with amino acid starvation

    • HRI activation with heme deficiency

  • Analyze site-specific phosphorylation patterns using site-specific antibodies

• Phosphorylation site mapping:

  • Use mass spectrometry with high sequence coverage to quantify relative phosphorylation at each site

  • Perform in vitro kinase assays with purified kinases to determine site preference

  • Analyze neighboring residue mutations (e.g., GST-eIF2α-AAA-S51-AAA) to assess context dependency

• Readout diversification:

  • Measure translational repression (puromycin incorporation)

  • Analyze stress granule formation (G3BP1 localization)

  • Assess downstream signaling activation (ATF4, CHOP induction)

  • Evaluate functional outcomes (autophagy, apoptosis, cell survival)

Recent research suggests that Ser49 and Ser51 may be the same residue named differently due to counting conventions, but any distinct biological effects would be revealed through these systematic approaches .

What are the best approaches for quantifying changes in EIF2S1 phosphorylation levels?

For precise quantification of EIF2S1 phosphorylation changes:

• Normalization strategies:

  • Dual detection: Always normalize phospho-EIF2S1 signal to total EIF2S1 levels in the same sample

  • Loading controls: Use stable housekeeping proteins like Tubulin or GAPDH for additional normalization

  • Phosphorylation ratio: Express results as the phospho-EIF2S1/total EIF2S1 ratio to account for expression variations

• Quantitative Western blotting:

  • Use fluorescent secondary antibodies for wider linear detection range

  • Implement standard curves with recombinant phosphoproteins

  • Perform technical replicates (n≥3) and biological replicates (n≥3)

  • Use image analysis software (ImageJ, Image Studio) with background subtraction

• Mass spectrometry-based approaches:

  • SILAC or TMT labeling for comparative quantification

  • Selected reaction monitoring (SRM) or parallel reaction monitoring (PRM) for targeted quantification

  • Phospho-enrichment techniques (titanium dioxide, IMAC) prior to MS analysis

• ELISA and flow cytometry:

  • Commercial phospho-EIF2S1 ELISA kits offer high throughput quantification

  • Flow cytometry (0.5 μg per 10^6 cells) enables single-cell phosphorylation analysis

  • Use calibration beads to ensure consistent detection across experiments

• Time-course considerations:

  • EIF2S1 phosphorylation is often dynamic and transient

  • Design appropriate time-point sampling based on the specific stress condition

  • Include both early (15-30 min) and later (4-8 hr) time points to capture peak phosphorylation and adaptation phases

These quantitative approaches provide robust data for statistical analysis and interpretation of EIF2S1 phosphorylation dynamics in various experimental conditions.

How does EIF2S1 phosphorylation coordinate with other translation control mechanisms?

EIF2S1 phosphorylation interfaces with multiple translation control mechanisms in a coordinated regulatory network:

• Integration with mTOR signaling:

  • While EIF2S1 phosphorylation inhibits global translation during stress, mTOR inhibition concurrently suppresses cap-dependent translation through 4E-BP1 phosphorylation

  • This dual inhibition provides comprehensive translational reprogramming during integrated stress responses

• Selective mRNA translation:

  • EIF2S1 phosphorylation preferentially enhances translation of ISR-specific mRNAs containing upstream open reading frames (uORFs), including transcriptional activators ATF4 and QRICH1

  • This selective translation enables stress-adaptive gene expression while global protein synthesis is attenuated

• UPR pathway coordination:

  • EIF2S1 phosphorylation influences all three branches of the unfolded protein response (UPR)

  • Research in phosphorylation-deficient cells revealed that EIF2S1 phosphorylation is required for cleavage-mediated activation of ATF6 and expression of genes in all three UPR pathways

  • This creates a coordinated response to endoplasmic reticulum stress

• Autophagy regulation interface:

  • EIF2S1 phosphorylation is essential for nuclear translocation of TFEB and TFE3, key transcription factors regulating autophagic gene expression

  • Transcription factors downstream of phosphorylated EIF2S1 (ATF4, ATF6, XBP1s) differentially rescue autophagy defects in phosphorylation-deficient cells

• miRNA pathway interaction:

  • Emerging evidence suggests cross-talk between EIF2S1 phosphorylation and miRNA-mediated translational repression

  • Stress conditions triggering EIF2S1 phosphorylation may alter miRNA biogenesis and function

This intricate network of interactions positions EIF2S1 phosphorylation as a central hub in translational control during cellular stress adaptation.

What is the significance of EIF2S1 phosphorylation in mitochondrial regulation and mitophagy?

Recent research has uncovered crucial roles for EIF2S1 phosphorylation in mitochondrial quality control:

• Direct activation of mitophagy:

  • Phosphorylation of EIF2S1/eIF2α by EIF2AK1/HRI specifically in response to mitochondrial damage promotes its relocalization to the mitochondrial surface

  • This relocalization triggers PRKN-independent mitophagy, establishing a direct mechanistic link between translational control and mitochondrial quality control

• Stress sensing integration:

  • Mitochondrial dysfunction leads to ROS production and oxidative stress, activating EIF2AK1/HRI

  • The subsequent EIF2S1 phosphorylation creates a feedback loop where translational reprogramming supports mitochondrial quality control

• Metabolic adaptation:

  • EIF2S1 phosphorylation-mediated translation of specific mRNAs alters cellular metabolism to accommodate mitochondrial dysfunction

  • This includes upregulation of genes involved in amino acid biosynthesis and mitochondrial proteostasis

• Coordination with PINK1/Parkin pathway:

  • While traditional mitophagy depends on the PINK1/Parkin pathway, EIF2S1 phosphorylation provides an alternative, PRKN-independent mechanism

  • This redundancy ensures robust mitochondrial quality control under various stress conditions

• Organelle cross-talk:

  • EIF2S1 phosphorylation establishes signaling between endoplasmic reticulum, where PERK is activated, and mitochondria

  • This inter-organelle communication coordinates cellular stress responses

This emerging role of EIF2S1 in mitochondrial regulation represents a significant expansion of our understanding beyond its canonical function in translational control, highlighting the interconnected nature of cellular stress response systems.

How can phospho-EIF2S1 biomarkers be developed for disease diagnosis or treatment monitoring?

Development of phospho-EIF2S1 biomarkers requires consideration of several key factors:

• Disease-specific phosphorylation profiles:

  • Neurodegenerative disorders: Chronic EIF2S1 phosphorylation correlates with disease progression

  • Cancer: Altered phosphorylation dynamics may indicate treatment resistance

  • Metabolic diseases: Tissue-specific phosphorylation patterns reflect stress response activation

• Sample collection and processing:

  • Tissue biopsies: Require immediate preservation of phosphorylation status with phosphatase inhibitors

  • Liquid biopsies: Explore extracellular vesicles containing phosphoproteins

  • Development of phospho-stable collection protocols is essential for clinical translation

• Detection technologies:

  • Multiplex phosphoprotein arrays with enhanced sensitivity

  • Mass spectrometry-based absolute quantification

  • Novel proximity ligation assays for improved sensitivity

  • Flow cytometry for single-cell phosphorylation profiling in blood cells

• Therapeutic monitoring applications:

  • Integrated stress response inhibitors (ISRIBs): Monitor treatment efficacy by tracking phospho-EIF2S1 levels

  • Kinase inhibitor therapy: Use phospho-EIF2S1 as a pharmacodynamic marker

  • Develop companion diagnostics for stress-response targeting therapies

• Validation requirements:

  • Establish reference ranges in healthy populations

  • Determine diurnal variation and stress-responsive fluctuations

  • Validate across diverse patient populations

  • Correlate with disease severity and progression metrics

The development of such biomarkers would significantly enhance our ability to monitor stress response activation in various pathological conditions and guide therapeutic interventions targeting the integrated stress response pathway.